Anti-CBR1 Antibody (2C9-B12-C4)

Anti-CBR1 Antibody (2C9-B12-C4)is available at Gentaur for Next week Delivery.

Description: NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol. Can convert prostaglandin E2 to prostaglandin F2-alpha. Can bind glutathione, which explains its higher affinity for glutathione-conjugated substrates. Catalyzes the reduction of S-nitrosoglutathione.

Immunogen Sequence:Recombinant human CBR1 protein fragments expressed in E.coli

Target Alternative Name:Carbonyl reductase [NADPH] 1, 15-hydroxyprostaglandin dehydrogenase [NADP(+)], NADPH-dependent carbonyl reductase 1, Prostaglandin 9-ketoreductase, Prostaglandin-E(2) 9-reductase, Short chain dehydrogenase/reductase family 21C member 1

Species Reactivities:Human

Tag Line:Monoclonal antibody to detect CBR1

Formulation:In PBS (pH 7.4) containing with 0.2% sodium azide, 50% glycerol

Purification: Affinity purified

Application:WB, IF

Positive Control:WB: HeLa, A431 and MDA-MB-468 cell lysates; IF: HeLa cells

Application And Usages:WB; 1:1000; IF; 1:100

Handling:The antibody solution should be gently mixed before use